Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Kidney Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
5 drugs · 8 active trials
17 drugs · 284 active trials
Data updated 8 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Atezolizumab | Phase 3 | Phase 3 | 12 | 4 | 5 | 25 | 0 | — | — | 2016-11 |
| Cyclophosphamide | Phase 3 | Phase 3 | 8 | 7 | 6 | 46 | 0 | — | — | 1990-05 |
| Durvalumab | Phase 3 | Phase 3 | 6 | 1 | 3 | 15 | 0 | — | — | Dec 19, 2013 |
| Carboplatin | Phase 3 | Phase 3 | 5 | 4 | 3 | 17 | 0 | — | — | 1992-10 |
| Doxorubicin | Phase 3 | Phase 3 | 3 | 3 | 9 | 19 | 0 | — | — | 1990-05 |
| Irinotecan | Phase 3 | Phase 3 | 3 | 2 | 1 | 9 | 0 | — | — | 1999-08 |
| Ipilimumab/Nivolumab Regimen | Phase 3 | Phase 3 | 3 | 0 | 1 | 8 | 0 | — | — | 2016-10 |
| Gemcitabine | Phase 3 | Phase 3 | 2 | 1 | 1 | 27 | 0 | — | — | 1998-10 |
| Etoposide | Phase 3 | Phase 3 | 2 | 2 | 5 | 13 | 0 | — | — | 1990-05 |
| Fluorouracil | Phase 3 | Phase 3 | 2 | 0 | 2 | 11 | 0 | — | — | 1996-08 |
| Vincristine | Phase 3 | Phase 3 | 2 | 2 | 7 | 11 | 0 | — | — | 1990-05 |
| Cisplatin | Phase 3 | Phase 3 | 2 | 1 | 1 | 9 | 0 | — | — | 1999-01 |
| Tremelimumab | Phase 3 | Phase 3 | 2 | 1 | 1 | 8 | 0 | — | — | 2006-11 |
| Savolitinib | Phase 3 | Phase 3 | 2 | 0 | 2 | 5 | 0 | — | — | Apr 30, 2014 |
| Prednisone | Phase 3 | Phase 3 | 2 | 1 | 1 | 3 | 0 | — | — | 1998-07 |
| Dactinomycin | Phase 3 | Phase 3 | 1 | 1 | 8 | 10 | 0 | — | — | 1993-07 |
| Ifosfamide | Phase 3 | Phase 3 | 1 | 1 | 2 | 8 | 0 | — | — | 1990-05 |
| Enzalutamide | Phase 3 | Phase 3 | 1 | 0 | 1 | 4 | 0 | — | — | Feb 11, 2015 |
| Chemotherapy | Phase 3 | Phase 3 | 1 | 0 | 1 | 3 | 0 | — | — | 1996-03 |
| Abexinostat | Phase 3 | Phase 3 | 1 | 1 | 1 | 1 | 0 | — | — | Jul 17, 2018 |
| Abiraterone | Phase 3 | Phase 3 | 1 | 0 | 1 | 1 | 0 | — | — | Jul 30, 2026 |
| Alectinib | Phase 3 | Phase 3 | 1 | 1 | 1 | 1 | 0 | — | — | Dec 18, 2023 |
| Fruquintinib | Phase 3 | Phase 3 | 1 | 0 | 1 | 1 | 0 | — | — | Oct 27, 2022 |
| Filgrastim | Phase 3 | Phase 3 | 0 | 0 | 4 | 17 | 0 | — | — | 1992-10 |
| Thalidomide | Phase 3 | Phase 3 | 0 | 0 | 1 | 5 | 0 | — | — | 1998-11 |
| Denosumab | Phase 3 | Phase 3 | 0 | 0 | 1 | 3 | 0 | — | — | Nov 16, 2009 |
| Dovitinib | Phase 3 | Phase 3 | 0 | 0 | 1 | 2 | 0 | — | — | 2011-03 |
| Peginterferon Alfa-2a | Phase 3 | Phase 3 | 0 | 0 | 1 | 1 | 0 | — | — | 2004-01 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.